What is the size of the AI In Cancer market in 2023?

The AI In Cancer market size is USD 985.5 Million in 2023.

What is the projected CAGR at which the AI In Cancer market is expected to grow at?

The AI In Cancer market is expected to grow at a CAGR of 35% (2024-2033).

List the key industry players of the AI In Cancer market?

Azra AI, IBM, Siemens Healthineers, Intel, GE Healthcare, NVIDIA, Digital Diagnostics Inc., AI, Median Technologies, Path AI, Other Key Players

Name the key areas of business for AI In Cancer?

The US, Canada, India, China, UK, Japan, & Germany are key areas of operation for the AI In Cancer Market.

Global AI In Cancer Market Size By Component (Software Solutions, Hardware and Services), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, and Other Cancer Types), By Treatment Type (Chemotherapy, Radiotherapy, Immunotherapy, and Other Treatment Type), By End User (Hospitals, Diagnostic Centers, Pharmaceutical Companies, Research Institutes and Other Segments), By Region and Companies-Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: July 2024
Report ID: 116326
Number of Pages: 381
Format:

- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
  - 2.2.1. Drivers
  - 2.2.2. Restraints
  - 2.2.3. Opportunities
  - 2.2.4. Key AI in Cancer Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
  - 2.9.1. List of Raw Materials Suppliers
  - 2.9.2. List of AI in Cancer Manufacturers
  - 2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-Economic Factors/Geopolitical Factors
- 3. Global AI in Cancer Market Analysis and Forecast, By Segment, 2024-2033
  - 3.1. Key Findings
  - 3.2. Global AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Component, 2024-2033
  - 3.3. Global AI in Cancer Market Attractiveness Analysis, By Component
    3.3.1. Software
    3.3.1.1. Insights
    3.3.1.2. Key Takeaways
    3.3.2. Hardware
    3.3.2.1. Insights
    3.3.2.2. Key Takeaways
    3.3.3. Services
    3.3.3.1. Insights
    3.3.3.2. Key Takeaways
  - 3.4. Global AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Cancer type, 2024-2033
  - 3.5. Global AI in Cancer Market Attractiveness Analysis, By Cancer type
    3.5.1. Breast cancer
    3.5.1.1. Insights
    3.5.1.2. Key Takeaways
    3.5.2. Lung cancer
    3.5.2.1. Insights
    3.5.2.2. Key Takeaways
    3.5.3. Prostate cancer
    3.5.3.1. Insights
    3.5.3.2. Key Takeaways
    3.5.4. Colorectal cancer
    3.5.4.1. Insights
    3.5.4.2. Key Takeaways
    3.5.5. Brain cancer
    3.5.5.1. Insights
    3.5.5.2. Key Takeaways
    3.5.6. Other types
    3.5.6.1. Insights
    3.5.6.2. Key Takeaways
  - 3.6. Global AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment type, 2024-2033
  - 3.7. Global AI in Cancer Market Attractiveness Analysis, By Treatment type
    3.7.1. Chemotherapy
    3.7.1.1. Insights
    3.7.1.2. Key Takeaways
    3.7.2. Radiotherapy
    3.7.2.1. Insights
    3.7.2.2. Key Takeaways
    3.7.3. Immunotherapy
    3.7.3.1. Insights
    3.7.3.2. Key Takeaways
    3.7.4. Other Cancer types
    3.7.4.1. Insights
    3.7.4.2. Key Takeaways
  - 3.8. Global AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2024-2033
  - 3.9. Global AI in Cancer Market Attractiveness Analysis, By End-User
    3.9.1. Hospitals
    3.9.1.1. Insights
    3.9.1.2. Key Takeaways
  - 3.9.2. Diagnostic Centres
    3.9.2.1. Insights
    3.9.2.2. Key Takeaways
  - 3.9.3. Pharmaceutical companies
    3.9.3.1. Insights
    3.9.3.2. Key Takeaways
  - 3.9.4. Research Institutes
    3.9.4.1. Insights
    3.9.4.2. Key Takeaways
  - 3.9.5. Others
    3.9.5.1. Insights
    3.9.5.2. Key Takeaways
- 4. Global AI in Cancer Market Analysis and Forecast, By Region, 2024-2033
  - 4.1. Key Findings
  - 4.2. Global AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2024-2033
    4.2.1. North America
    4.2.1.1. Regional Insights
    4.2.2. Europe
    4.2.2.1. Regional Insights
    4.2.3. Asia Pacific
    4.2.3.1. Regional Insights
    4.2.4. Latin America
    4.2.4.1. Regional Insights
    4.2.5. Middle East & Africa
    4.2.5.1. Regional Insights
  - 4.3. Global AI in Cancer Market Attractiveness Analysis, By Region
- 5. North America AI in Cancer Market Analysis and Forecast, 2024-2033
  - 5.1. Key Findings
  - 5.2. North America AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Component, 2024-2033
  - 5.3. North America AI in Cancer Market Attractiveness Analysis, By Component
  - 5.4. North America AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Cancer type, 2024-2033
  - 5.5. North America AI in Cancer Market Attractiveness Analysis, By Cancer type
  - 5.6. North America AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment type, 2024-2033
  - 5.7. North America AI in Cancer Market Attractiveness Analysis, By Treatment type
  - 5.8. North America AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2024-2033
  - 5.9. North America AI in Cancer Market Attractiveness Analysis, By End User
  - 5.10. North America AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 5.11. North America AI in Cancer Market Attractiveness Analysis, By Country
    5.11.1. The US
    5.11.2. Canada
- 6. Europe AI in Cancer Market Analysis and Forecast, 2024-2033
  - 6.1. Key Findings
  - 6.2. Europe AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Component, 2024-2033
  - 6.3. Europe AI in Cancer Market Attractiveness Analysis, By Component
  - 6.4. Europe AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Cancer type, 2024-2033
  - 6.5. Europe AI in Cancer Market Attractiveness Analysis, By Cancer type
  - 6.6. Europe AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment type, 2024-2033
  - 6.7. Europe AI in Cancer Market Attractiveness Analysis, By Treatment type
  - 6.8. Europe AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2024-2033
  - 6.9. Europe AI in Cancer Market Attractiveness Analysis, By End User
  - 6.10. Europe AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 6.11. Europe AI in Cancer Market Attractiveness Analysis, By Country
    6.11.1. Germany
    6.11.2. The UK
    6.11.3. France
    6.11.4. Spain
    6.11.5. Italy
    6.11.6. Russia
    6.11.7. Netherlands
    6.11.8. Rest of Europe
- 7. Asia Pacific AI in Cancer Market Analysis and Forecast, 2024-2033
  - 7.1. Key Findings
  - 7.2. Asia Pacific AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Component, 2024-2033
  - 7.3. Asia Pacific AI in Cancer Market Attractiveness Analysis, By Component
  - 7.4. Asia Pacific AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Cancer type, 2024-2033
  - 7.5. Asia Pacific AI in Cancer Market Attractiveness Analysis, By Cancer type
  - 7.6. Asia Pacific AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment type, 2024-2033
  - 7.7. Asia Pacific AI in Cancer Market Attractiveness Analysis, By Treatment type
  - 7.8. Asia Pacific AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2024-2033
  - 7.9. Asia Pacific AI in Cancer Market Attractiveness Analysis, By End User
  - 7.10. Asia Pacific AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 7.11. Asia Pacific AI in Cancer Market Attractiveness Analysis, By Country
    7.11.1. China
    7.11.2. Japan
    7.11.3. South Korea
    7.11.4. India
    7.11.5. New Zealand
    7.11.6. Singapore
    7.11.7. Thailand
    7.11.8. Vietnam
    7.11.9. Rest of Asia Pacific
- 8. Latin America AI in Cancer Market Analysis and Forecast, 2024-2033
  - 8.1. Key Findings
  - 8.2. Latin America AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Component, 2024-2033
  - 8.3. Latin America AI in Cancer Market Attractiveness Analysis, By Component
  - 8.4. Latin America AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Cancer type, 2024-2033
  - 8.5. Latin America AI in Cancer Market Attractiveness Analysis, By Cancer type
  - 8.6. Latin America AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment type, 2024-2033
  - 8.7. Latin America AI in Cancer Market Attractiveness Analysis, By Treatment type
  - 8.8. Latin America AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2024-2033
  - 8.9. Latin America AI in Cancer Market Attractiveness Analysis, By End User
  - 8.10. Latin America AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 8.11. Latin America AI in Cancer Market Attractiveness Analysis, By Country
    8.11.1. Brazil
    8.11.2. Mexico
    8.11.3. Rest of Latin America
- 9. Middle East & Africa AI in Cancer Market Analysis and Forecast, 2024-2033
  - 9.1. Key Findings
  - 9.2. Middle East & Africa AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Component, 2024-2033
  - 9.3. Middle East & Africa AI in Cancer Market Attractiveness Analysis, By Component
  - 9.4. Middle East & Africa AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Cancer type, 2024-2033
  - 9.5. Middle East & Africa AI in Cancer Market Attractiveness Analysis, By Cancer type
  - 9.6. Middle East & Africa AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment type, 2024-2033
  - 9.7. Middle East & Africa AI in Cancer Market Attractiveness Analysis, By Treatment type
  - 9.8. Middle East & Africa AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2024-2033
  - 9.9. Middle East & Africa AI in Cancer Market Attractiveness Analysis, By End User
  - 9.10. Middle East & Africa AI in Cancer Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 9.11. Middle East & Africa AI in Cancer Market Attractiveness Analysis, By Country
    9.11.1. South Africa
    9.11.2. Saudi Arabia
    9.11.3. UAE
    9.11.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    10.7.1. Azra AI
    10.7.1.1. Company Details
    10.7.1.2. Business Overview
    10.7.1.3. Product Portfolio
    10.7.1.4. Financial Insights
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.1.6. SWOT Analysis
    10.7.1.7. Geographic Footprint
    10.7.2. IBM
    10.7.2.1. Company Details
    10.7.2.2. Business Overview
    10.7.2.3. Product Portfolio
    10.7.2.4. Financial Insights
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.2.6. SWOT Analysis
    10.7.2.7. Geographic Footprint
    10.7.3. Siemens Healthineers
    10.7.3.1. Company Details
    10.7.3.2. Business Overview
    10.7.3.3. Product Portfolio
    10.7.3.4. Financial Insights
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.3.6. SWOT Analysis
    10.7.3.7. Geographic Footprint
    10.7.4. Intel
    10.7.4.1. Company Details
    10.7.4.2. Business Overview
    10.7.4.3. Product Portfolio
    10.7.4.4. Financial Insights
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.4.6. SWOT Analysis
    10.7.4.7. Geographic Footprint
    10.7.5. GE Healthcare
    10.7.5.1. Company Details
    10.7.5.2. Business Overview
    10.7.5.3. Product Portfolio
    10.7.5.4. Financial Insights
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.5.6. SWOT Analysis
    10.7.5.7. Geographic Footprint
    10.7.6. NVIDIA
    10.7.6.1. Company Details
    10.7.6.2. Business Overview
    10.7.6.3. Product Portfolio
    10.7.6.4. Financial Insights
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.6.6. SWOT Analysis
    10.7.6.7. Geographic Footprint
    10.7.7. Digital Technologies Inc
    10.7.7.1. Company Details
    10.7.7.2. Business Overview
    10.7.7.3. Product Portfolio
    10.7.7.4. Financial Insights
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.7.6. SWOT Analysis
    10.7.7.7. Geographic Footprint
    10.7.8. AI
    10.7.8.1. Company Details
    10.7.8.2. Business Overview
    10.7.8.3. Product Portfolio
    10.7.8.4. Financial Insights
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.8.6. SWOT Analysis
    10.7.8.7. Geographic Footprint
    10.7.9. Median Technologies
    10.7.9.1. Company Details
    10.7.9.2. Business Overview
    10.7.9.3. Product Portfolio
    10.7.9.4. Financial Insights
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.9.6. SWOT Analysis
    10.7.9.7. Geographic Footprint
    10.7.10. Path AI
    10.7.10.1. Company Details
    10.7.10.2. Business Overview
    10.7.10.3. Product Portfolio
    10.7.10.4. Financial Insights
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.10.6. SWOT Analysis
    10.7.10.7. Geographic Footprint
    10.7.11. Other Key Players
    10.7.11.1. Company Details
    10.7.11.2. Business Overview
    10.7.11.3. Product Portfolio
    10.7.11.4. Financial Insights
    10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.11.6. SWOT Analysis
    10.7.11.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
- List of Tables
  - Table 1. Global AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 2. Global AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 3. Global AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 4. Global AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 5. Global AI in Cancer Market Value (US$ Mn), By Region, 2024-2033
  - Table 6. North America AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 7. North America AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 8. North America AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 9. North America AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 10. North America AI in Cancer Market Value (US$ Mn), By Country, 2024-2033
  - Table 11. The US AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 12. The US AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 13. The US AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 14. The US AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 15. Canada AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 16. Canada AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 17. Canada AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 18. Canada AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 19. Europe AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 20. Europe AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 21. Europe AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 22. Europe AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 23. Europe AI in Cancer Market Value (US$ Mn), By Country, 2024-2033
  - Table 24. Germany AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 25. Germany AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 26. Germany AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 27. Germany AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 28. The UK AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 29. The UK AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 30. The UK AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 31. The UK AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 32. France AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 33. France AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 34. France AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 35. France AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 36. Spain AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 37. Spain AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 38. Spain AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 39. Spain AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 40. Italy AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 41. Italy AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 42. Italy AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 43. Italy AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 44. Russia AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 45. Russia AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 46. Russia AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 47. Russia AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 48. Netherlands AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 49. Netherlands AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 50. Netherlands AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 51. Netherlands AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 52. Rest of Europe AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 53. Rest of Europe AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 54. Rest of Europe AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 55. Rest of Europe AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 56. Asia Pacific AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 57. Asia Pacific AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 58. Asia Pacific AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 59. Asia Pacific AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 60. Asia Pacific AI in Cancer Market Value (US$ Mn), By Country, 2024-2033
  - Table 61. China AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 62. China AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 63. China AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 64. China AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 65. India AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 66. Global AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 67. Global AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 68. Global AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 69. Japan AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 70. Japan AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 71. Japan AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 72. Japan AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 73. South Korea AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 74. South Korea AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 75. South Korea AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 76. South Korea AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 77. New Zealand AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 78. New Zealand AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 79. New Zealand AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 80. New Zealand AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 81. Singapore AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 82. Singapore AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 83. Singapore AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 84. Singapore AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 85. Thailand AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 86. Thailand AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 87. Thailand AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 88. Thailand AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 89. Vietnam AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 90. Vietnam AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 91. Vietnam AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 92. Vietnam AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 93. Rest of Asia Pacific AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 94. Rest of Asia Pacific AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 95. Rest of Asia Pacific AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 96. Rest of Asia Pacific AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 97. Latin America AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 98. Latin America AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 99. Latin America AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 100. Latin America AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 101. Latin America AI in Cancer Market Value (US$ Mn), By Country, 2024-2033
  - Table 102. Brazil AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 103. Brazil AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 104. Brazil AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 105. Brazil AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 106. Mexico AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 107. Mexico AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 108. Mexico AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 109. Mexico AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 110. Rest of Latin America AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 111. Rest of Latin America AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 112. Rest of Latin America AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 113. Rest of Latin America AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 114. Middle East & Africa AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 115. Middle East & Africa AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 116. Middle East & Africa AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 117. Middle East & Africa AI in Cancer Market Value (US$ Mn), By End-User, 2024-2033
  - Table 118. Middle East & Africa AI in Cancer Market Value (US$ Mn), By Country, 2024-2033
  - Table 119. South Africa AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 120. South Africa AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 121. South Africa AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 122. South Africa AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 123. Saudi Arabia AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 124. Saudi Arabia AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 125. Saudi Arabia AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 126. Saudi Arabia AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 127. UAE AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 128. UAE AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 129. UAE AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 130. UAE AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
  - Table 131. Rest of Middle East & Africa AI in Cancer Market Value (US$ Mn), By Component, 2024-2033
  - Table 132. Rest of Middle East & Africa AI in Cancer Market Value (US$ Mn), By Cancer type, 2024-2033
  - Table 133. Rest of Middle East & Africa AI in Cancer Market Value (US$ Mn), By Treatment type, 2024-2033
  - Table 134. Rest of Middle East & Africa AI in Cancer Market Value (US$ Mn), By End User, 2024-2033
- List of Figures
  - Figure 1. Global AI in Cancer Market Snapshot: Market Value (US$ Mn), 2024-2033
  - Figure 2. Opportunity Map
  - Figure 3. Opportunity Orbit
  - Figure 4. Regional Market Share and BPS Analysis in AI in Cancer Market
  - Figure 5. Global AI in Cancer Market Analysis, By Component, 2018, 2023 and 2033
  - Figure 6. Global AI in Cancer Market Attractiveness Analysis, By Component
  - Figure 7. Global AI in Cancer Market Analysis, By Cancer type, 2018, 2023 and 2033
  - Figure 8. Global AI in Cancer Market Attractiveness Analysis, By Cancer type
  - Figure 9. Global AI in Cancer Market Analysis, By Treatment type, 2018, 2023 and 2033
  - Figure 10. Global AI in Cancer Market Attractiveness Analysis, By Treatment type
  - Figure 11. Global AI in Cancer Market Analysis, By End User, 2018, 2023 and 2033
  - Figure 12. Global AI in Cancer Market Attractiveness Analysis, By End User
  - Figure 13. North America AI in Cancer Market Analysis, By Component, 2018, 2023 and 2033
  - Figure 14. North America AI in Cancer Market Attractiveness Analysis, By Component
  - Figure 15. North America AI in Cancer Market (US$ Mn), by Software, 2024-2033
  - Figure 16. North America AI in Cancer Market (US$ Mn), by Hardware, 2024-2033
  - Figure 17. North America AI in Cancer Market (US$ Mn), by Services, 2024-2033
  - Figure 18. North America AI in Cancer Market Analysis, By Cancer type, 2018, 2023 and 2033
  - Figure 19. North America AI in Cancer Market Attractiveness Analysis, By Cancer type
  - Figure 20. North America AI in Cancer Market (US$ Mn), by Breast cancer, 2024-2033
  - Figure 21. North America AI in Cancer Market (US$ Mn), by Lung cancer, 2024-2033
  - Figure 22. North America AI in Cancer Market (US$ Mn), by Prostate cancer, 2024-2033
  - Figure 23. North America AI in Cancer Market (US$ Mn), by Colorectal cancer, 2024-2033
  - Figure 24. North America AI in Cancer Market (US$ Mn), by Brain cancer, 2024-2033
  - Figure 25. North America AI in Cancer Market (US$ Mn), by Other types, 2024-2033
  - Figure 26. North America AI in Cancer Market Analysis, By Treatment type, 2018, 2023 and 2033
  - Figure 27. North America AI in Cancer Market Attractiveness Analysis, By Treatment type
  - Figure 28. North America AI in Cancer Market (US$ Mn), by Chemotherapy, 2024-2033
  - Figure 29. North America AI in Cancer Market (US$ Mn), by Radiotherapy, 2024-2033
  - Figure 30. North America AI in Cancer Market (US$ Mn), by Immunotherapy, 2024-2033
  - Figure 31. North America AI in Cancer Market (US$ Mn), by Other cancer types, 2024-2033
  - Figure 32. North America AI in Cancer Market Analysis, By End User, 2018, 2023 and 2033
  - Figure 33. North America AI in Cancer Market Attractiveness Analysis, By End User
  - Figure 34. North America AI in Cancer Market (US$ Mn), by Hospitals, 2024-2033
  - Figure 35. North America AI in Cancer Market (US$ Mn), by Diagnostic Centres, 2024-2033
  - Figure 36. North America AI in Cancer Market (US$ Mn), by Pharmaceutical companies, 2024-2033
  - Figure 37. North America AI in Cancer Market (US$ Mn), by Research Institutes, 2024-2033
  - Figure 38. North America AI in Cancer Market (US$ Mn), by Others, 2024-2033
  - Figure 39. North America AI in Cancer Market Analysis, By Country, 2018, 2023 and 2033
  - Figure 40. North America AI in Cancer Market Attractiveness Analysis, By Country
  - Figure 41. Europe AI in Cancer Market Analysis, By Component, 2018, 2023 and 2033
  - Figure 42. Europe AI in Cancer Market Attractiveness Analysis, By Component
  - Figure 43. Europe AI in Cancer Market (US$ Mn), by Software, 2024-2033
  - Figure 44. Europe AI in Cancer Market (US$ Mn), by Hardware, 2024-2033
  - Figure 45. Europe AI in Cancer Market (US$ Mn), by Services, 2024-2033
  - Figure 46. Europe AI in Cancer Market Analysis, By Cancer type, 2018, 2023 and 2033
  - Figure 47. Europe AI in Cancer Market Attractiveness Analysis, By Cancer type
  - Figure 48. Europe AI in Cancer Market (US$ Mn), by Breast cancer, 2024-2033
  - Figure 49. Europe AI in Cancer Market (US$ Mn), by Lung cancer, 2024-2033
  - Figure 50. Europe AI in Cancer Market (US$ Mn), by Prostate cancer, 2024-2033
  - Figure 51. Europe AI in Cancer Market (US$ Mn), by Colorectal cancer, 2024-2033
  - Figure 52. Europe AI in Cancer Market (US$ Mn), by Brain cancer, 2024-2033
  - Figure 53. Europe AI in Cancer Market (US$ Mn), by Other types, 2024-2033
  - Figure 54. Europe AI in Cancer Market Analysis, By Treatment type, 2018, 2023 and 2033
  - Figure 55. Europe AI in Cancer Market Attractiveness Analysis, By Treatment type
  - Figure 56. Europe AI in Cancer Market (US$ Mn), by Chemotherapy, 2024-2033
  - Figure 57. Europe AI in Cancer Market (US$ Mn), by Radiotherapy, 2024-2033
  - Figure 58. Europe AI in Cancer Market (US$ Mn), by Immunotherapy, 2024-2033
  - Figure 59. Europe AI in Cancer Market (US$ Mn), by Other cancer types, 2024-2033
  - Figure 60. Europe AI in Cancer Market Analysis, By End User, 2018, 2023 and 2033
  - Figure 61. Europe AI in Cancer Market Attractiveness Analysis, By End User
  - Figure 62. Europe AI in Cancer Market (US$ Mn), by Hospitals, 2024-2033
  - Figure 63. Europe AI in Cancer Market (US$ Mn), by Diagnostic Centres, 2024-2033
  - Figure 64. Europe AI in Cancer Market (US$ Mn), by Pharmaceutical companies, 2024-2033
  - Figure 65. Europe AI in Cancer Market (US$ Mn), by Research Institutes, 2024-2033
  - Figure 66. Europe AI in Cancer Market (US$ Mn), by Others, 2024-2033
  - Figure 67. Europe AI in Cancer Market Analysis, By Country, 2018, 2023 and 2033
  - Figure 68. Europe AI in Cancer Market Attractiveness Analysis, By Country
  - Figure 69. Asia Pacific AI in Cancer Market Analysis, By Component, 2018, 2023 and 2033
  - Figure 70. Asia Pacific AI in Cancer Market Attractiveness Analysis, By Component
  - Figure 71. Asia Pacific AI in Cancer Market (US$ Mn), by Software, 2024-2033
  - Figure 72. Asia Pacific AI in Cancer Market (US$ Mn), by Hardware, 2024-2033
  - Figure 73. Asia Pacific AI in Cancer Market (US$ Mn), by Services, 2024-2033
  - Figure 74. Asia Pacific AI in Cancer Market Analysis, By Cancer type, 2018, 2023 and 2033
  - Figure 75. Asia Pacific AI in Cancer Market Attractiveness Analysis, By Cancer type
  - Figure 76. Asia Pacific AI in Cancer Market (US$ Mn), by Breast cancer, 2024-2033
  - Figure 77. Asia Pacific AI in Cancer Market (US$ Mn), by Lung cancer, 2024-2033
  - Figure 78. Asia Pacific AI in Cancer Market (US$ Mn), by Prostate cancer, 2024-2033
  - Figure 79. Asia Pacific AI in Cancer Market (US$ Mn), by Colorectal cancer, 2024-2033
  - Figure 80. Asia Pacific AI in Cancer Market (US$ Mn), by Brain cancer, 2024-2033
  - Figure 81. Asia Pacific AI in Cancer Market (US$ Mn), by Other types, 2024-2033
  - Figure 82. Asia Pacific AI in Cancer Market Analysis, By Treatment type, 2018, 2023 and 2033
  - Figure 83. Asia Pacific AI in Cancer Market Attractiveness Analysis, By Treatment type
  - Figure 84. Asia Pacific AI in Cancer Market (US$ Mn), by Chemotherapy, 2024-2033
  - Figure 85. Asia Pacific AI in Cancer Market (US$ Mn), by Radiotherapy, 2024-2033
  - Figure 86. Asia Pacific AI in Cancer Market (US$ Mn), by Immunotherapy, 2024-2033
  - Figure 87. Asia Pacific AI in Cancer Market (US$ Mn), by Others, 2024-2033
  - Figure 88. Asia Pacific AI in Cancer Market Analysis, By End User, 2018, 2023 and 2033
  - Figure 89. Asia Pacific AI in Cancer Market Attractiveness Analysis, By End User
  - Figure 90. Asia Pacific AI in Cancer Market (US$ Mn), by Hospitals, 2024-2033
  - Figure 91. Asia Pacific AI in Cancer Market (US$ Mn), by Diagnostic Centres, 2024-2033
  - Figure 92. Asia Pacific AI in Cancer Market (US$ Mn), by Pharmaceutical companies, 2024-2033
  - Figure 93. Asia Pacific AI in Cancer Market (US$ Mn), by Research Institutes, 2024-2033
  - Figure 94. Asia Pacific AI in Cancer Market (US$ Mn), by Others, 2024-2033
  - Figure 95. Asia Pacific AI in Cancer Market Analysis, By Country, 2018, 2023 and 2033
  - Figure 96. Asia Pacific AI in Cancer Market Attractiveness Analysis, By Country
  - Figure 97. Latin America AI in Cancer Market Analysis, By Component, 2018, 2023 and 2033
  - Figure 98. Latin America AI in Cancer Market Attractiveness Analysis, By Component
  - Figure 99. Latin America AI in Cancer Market (US$ Mn), by Software, 2024-2033
  - Figure 100. Latin America AI in Cancer Market (US$ Mn), by Hardware, 2024-2033
  - Figure 101. Latin America AI in Cancer Market (US$ Mn), by Services, 2024-2033
  - Figure 102. Latin America AI in Cancer Market Analysis, By Cancer type, 2018, 2023 and 2033
  - Figure 103. Latin America AI in Cancer Market Attractiveness Analysis, By Cancer type
  - Figure 104. Latin America AI in Cancer Market (US$ Mn), by Breast cancer, 2024-2033
  - Figure 105. Latin America AI in Cancer Market (US$ Mn), by Lung cancer, 2024-2033
  - Figure 106. Latin America AI in Cancer Market (US$ Mn), by Prostate cancer, 2024-2033
  - Figure 107. Latin America AI in Cancer Market (US$ Mn), by Colorectal cancer, 2024-2033
  - Figure 108. Latin America AI in Cancer Market (US$ Mn), by Brain cancer, 2024-2033
  - Figure 109. Latin America AI in Cancer Market (US$ Mn), by Other types, 2024-2033
  - Figure 110. Latin America AI in Cancer Market Analysis, By Treatment type, 2018, 2023 and 2033
  - Figure 111. Latin America AI in Cancer Market Attractiveness Analysis, By Treatment type
  - Figure 112. Latin America AI in Cancer Market (US$ Mn), by Chemotherapy, 2024-2033
  - Figure 113. Latin America AI in Cancer Market (US$ Mn), by Radiotherapy, 2024-2033
  - Figure 114. Latin America AI in Cancer Market (US$ Mn), by Immunotherapy, 2024-2033
  - Figure 115. Latin America AI in Cancer Market (US$ Mn), by Other cancer types, 2024-2033
  - Figure 116. Latin America AI in Cancer Market Analysis, By End User, 2018, 2023 and 2033
  - Figure 117. Latin America AI in Cancer Market Attractiveness Analysis, By End User
  - Figure 118. Latin America AI in Cancer Market (US$ Mn), by Hospitals, 2024-2033
  - Figure 119. Latin America AI in Cancer Market (US$ Mn), by Diagnostic Centres, 2024-2033
  - Figure 120. Latin America AI in Cancer Market (US$ Mn), by Pharmaceutical companies, 2024-2033
  - Figure 121. Latin America AI in Cancer Market (US$ Mn), by Research Institutes, 2024-2033
  - Figure 122. Latin America AI in Cancer Market (US$ Mn), by Others, 2024-2033
  - Figure 123. Latin America AI in Cancer Market Analysis, By Country, 2018, 2023 and 2033
  - Figure 124. Latin America AI in Cancer Market Attractiveness Analysis, By Country
  - Figure 125. Middle East & Africa AI in Cancer Market Analysis, By Component, 2018, 2023 and 2033
  - Figure 126. Middle East & Africa AI in Cancer Market Attractiveness Analysis, By Component
  - Figure 127. Middle East & Africa AI in Cancer Market (US$ Mn), by Software, 2024-2033
  - Figure 128. Middle East & Africa AI in Cancer Market (US$ Mn), by Hardware, 2024-2033
  - Figure 129. Middle East & Africa AI in Cancer Market (US$ Mn), by Services, 2024-2033
  - Figure 130. Middle East & Africa AI in Cancer Market Analysis, By Cancer type, 2018, 2023 and 2033
  - Figure 131. Middle East & Africa AI in Cancer Market Attractiveness Analysis, By Cancer type
  - Figure 132. Middle East & Africa AI in Cancer Market (US$ Mn), by Breast cancer, 2024-2033
  - Figure 133. Middle East & Africa AI in Cancer Market (US$ Mn), by Lung cancer, 2024-2033
  - Figure 134. Middle East & Africa AI in Cancer Market (US$ Mn), by Prostate cancer, 2024-2033
  - Figure 135. Middle East & Africa AI in Cancer Market (US$ Mn), by Colorectal cancer, 2024-2033
  - Figure 136. Middle East & Africa AI in Cancer Market (US$ Mn), by Brain cancer, 2024-2033
  - Figure 137. Middle East & Africa AI in Cancer Market (US$ Mn), by Other types, 2024-2033
  - Figure 138. Middle East & Africa AI in Cancer Market Analysis, By Treatment type, 2018, 2023 and 2033
  - Figure 139. Middle East & Africa AI in Cancer Market Attractiveness Analysis, By Treatment type
  - Figure 140. Middle East & Africa AI in Cancer Market (US$ Mn), by Chemotherapy, 2024-2033
  - Figure 141. Middle East & Africa AI in Cancer Market (US$ Mn), by Radiotherapy, 2024-2033
  - Figure 142. Middle East & Africa AI in Cancer Market (US$ Mn), by Immunotherapy, 2024-2033
  - Figure 143. Middle East & Africa AI in Cancer Market (US$ Mn), by Other cancer types, 2024-2033
  - Figure 144. Middle East & Africa AI in Cancer Market Analysis, By End User, 2018, 2023 and 2033
  - Figure 145. Middle East & Africa AI in Cancer Market Attractiveness Analysis, By End User
  - Figure 146. Middle East & Africa AI in Cancer Market (US$ Mn), by Hospitals, 2024-2033
  - Figure 147. Middle East & Africa AI in Cancer Market (US$ Mn), by Diagnostic Centres, 2024-2033
  - Figure 148. Middle East & Africa AI in Cancer Market (US$ Mn), by Pharmaceutical companies, 2024-2033
  - Figure 149. Middle East & Africa AI in Cancer Market (US$ Mn), by Research Institutes, 2024-2033
  - Figure 150. Middle East & Africa AI in Cancer Market (US$ Mn), by Others, 2024-2033
  - Figure 151. Middle East & Africa AI in Cancer Market Analysis, By Country, 2018, 2023 and 2033
  - Figure 152. Middle East & Africa AI in Cancer Market Attractiveness Analysis, By Country
- Azra AI
- International Business Machines Corporation Company Profile
- Siemens Healthineers
- Intel
- GE Healthcare
- NVIDIA
- Digital Diagnostics Inc.
- Air Products & Chemicals, Inc. Company Profile
- Median Technologies
- Path AI
- Other Key Players
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)